Led by the COVID-19 pandemic effects, and given the primitively evolving health issues & needs, healthcare and pharmaceutical industry has gained significant momentum in the recent years. India being a major pharmaceutical hub witnessed huge demands from several countries across the globe for sourcing the medical supplies and drugs. According to ResearchAndMarkets. com's report, the Indian Active Pharmaceutical Ingredients market stood at $11806.93 million in 2021 and is expected to grow at a CAGR of 12.24 percent by 2027. The factor attributing this growth is the high growth of the biopharmaceutical sector in the country. But what is leading on to this elevation in demands is the increasing geriatric population in India that is further expected to boost the demand through 2027. The growing prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, respiratory disorders, among others is an addition to the ongoing boost in the market. This demand has led to the development of manufacturing facilities in the country and improved the status of domestic players to provide for the country’s emerging needs and world around. Also as the government turns supportive introducing policies such as Atmanirbhar Bharat, Pharma Vision 2020, Production Linked Incentive Scheme, among others, it is further expected to witness lucrative opportunities coming forth for the growth of overall pharmaceutical industry and the...